However, clinical observations have found that some patients do not respond well to anti-VEGF drugs, and macular edema still persists under regular anti-VEGF drug treatment (Pulido et al., 2016; Bajor et al., 2017). This evidence concerns the gene VEGFA and macular retinal edema.